AU1638801A - Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy - Google Patents

Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy

Info

Publication number
AU1638801A
AU1638801A AU16388/01A AU1638801A AU1638801A AU 1638801 A AU1638801 A AU 1638801A AU 16388/01 A AU16388/01 A AU 16388/01A AU 1638801 A AU1638801 A AU 1638801A AU 1638801 A AU1638801 A AU 1638801A
Authority
AU
Australia
Prior art keywords
production
nucleic acid
pharmaceutical composition
gene therapy
lipid complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16388/01A
Other languages
English (en)
Inventor
Jens Schletter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARDION AG
Original Assignee
Cardiogene Gentherapeutische Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiogene Gentherapeutische Systeme AG filed Critical Cardiogene Gentherapeutische Systeme AG
Publication of AU1638801A publication Critical patent/AU1638801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU16388/01A 1999-09-15 2000-09-14 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy Abandoned AU1638801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999144262 DE19944262A1 (de) 1999-09-15 1999-09-15 Pharmazeutische Zusammensetzung in Form eines Nukleinsäure-Lipid-Komplexes, ihre Herstellung und Verwendung in der Gentherapie
DE19944262 1999-09-15
PCT/EP2000/008996 WO2001019400A2 (de) 1999-09-15 2000-09-14 Pharmazeutische zusammensetzung in form eines nukleinsäure-lipid-komplexes, ihre herstellung und verwendung in der gentherapie

Publications (1)

Publication Number Publication Date
AU1638801A true AU1638801A (en) 2001-04-17

Family

ID=7922150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16388/01A Abandoned AU1638801A (en) 1999-09-15 2000-09-14 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy

Country Status (4)

Country Link
EP (1) EP1216027A2 (de)
AU (1) AU1638801A (de)
DE (1) DE19944262A1 (de)
WO (1) WO2001019400A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1512393A1 (de) * 2003-09-08 2005-03-09 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Verfahren zur Herstellung von homogenen Liposomen und Lipoplexen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658565A (en) * 1994-06-24 1997-08-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Inducible nitric oxide synthase gene for treatment of disease
DE4411402A1 (de) * 1994-03-31 1995-10-05 Juergen Schrader DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
ATE186546T1 (de) * 1994-12-28 1999-11-15 Max Delbrueck Centrum Neues cholesterolderivat für den liposomalen gentransfer
US5660855A (en) * 1995-02-10 1997-08-26 California Institute Of Technology Lipid constructs for targeting to vascular smooth muscle tissue
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
CA2214029A1 (en) * 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
AU707734B2 (en) * 1995-06-07 1999-07-15 Regents Of The University Of California, The Stabilization of polynucleotide complexes
CA2222328C (en) * 1995-06-07 2012-01-10 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5753262A (en) * 1995-06-07 1998-05-19 Aronex Pharmaceuticals, Inc. Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
EP0941066B1 (de) * 1996-08-26 2003-10-29 Transgene S.A. Kationische lipid-nukleinsäure komplexe
WO1998044934A1 (en) * 1997-04-07 1998-10-15 Rutgers, The State University Of New Jersey Cytokine and cisplatin-based gene therapy of carcinomas
DE19729769A1 (de) * 1997-07-11 1999-01-14 Cardiogene Gentherapeutische S Transfektionssystem, seine Herstellung und Verwendung in der somatischen Gentherapie

Also Published As

Publication number Publication date
WO2001019400A2 (de) 2001-03-22
EP1216027A2 (de) 2002-06-26
WO2001019400A3 (de) 2002-02-14
DE19944262A1 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
HUP0201010A3 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
AU6069300A (en) Novel human genes and gene expression products
AU3997300A (en) Gene sequence variations with utility in determining the treatment of disease
AU2003293649A1 (en) Novel xanthine derivatives, the production and the use thereof in the form of drugs
AU1887999A (en) Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU4303600A (en) Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
EP1323735A4 (de) Gene mit bezug zu arzneimitteltoleranz und anwendung derselben
AU2001260110A1 (en) Novel LHRH-antagonists, Production and Use Thereof as Medicament
AU4417000A (en) Novel pharmaceutical composition suitable for gene therapy
AU5068700A (en) Ceramic material to be utilized in the field of medicine, use of the same, and method for the production thereof
AU1638801A (en) Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy
IL145041A0 (en) Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2153401A (en) Gene expression in biological conditions
AU6773200A (en) Egfh2 genes and gene products
AU5483600A (en) Pharmaceutical materials and methods for their preparation and use
AU5088600A (en) Gene therapy products
AU2352301A (en) Gene expression in corneal diseases
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase